|
HS Code |
533178 |
| Chemical Name | L-Glutamine Methyl Ester Hydrochloride |
| Molecular Formula | C6H13ClN2O3 |
| Molecular Weight | 196.63 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water |
| Cas Number | 107619-64-9 |
| Purity | Typically ≥98% |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Synonyms | L-Glutaminic acid, methyl ester, monohydrochloride |
| Usage | Intermediate for peptide synthesis |
| Ph Value | Approximately 4.0-6.0 (1% solution in water) |
| Stability | Stable under recommended storage conditions |
As an accredited L-Glutamine Methyl Ester Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, tightly sealed plastic bottle containing 100 grams of L-Glutamine Methyl Ester Hydrochloride; labeled with product name, purity, and safety information. |
| Shipping | L-Glutamine Methyl Ester Hydrochloride is shipped in tightly sealed, moisture-proof containers to maintain stability and purity. It should be handled with appropriate protective gear and stored at room temperature or as specified. The package is clearly labeled, and shipping complies with local regulations for non-hazardous laboratory chemicals. |
| Storage | L-Glutamine Methyl Ester Hydrochloride should be stored in a cool, dry, well-ventilated area away from direct sunlight and incompatible substances. Keep the container tightly closed and sealed when not in use. Store at 2–8°C (refrigerated) to maintain stability and prevent degradation. Avoid exposure to moisture and excessive heat. Follow appropriate safety guidelines and consult the manufacturer's recommendations for extended storage. |
Applications of L-Glutamine Methyl Ester Hydrochloride in Industrial ManufacturingL-Glutamine Methyl Ester Hydrochloride serves as a functional intermediate in multiple chemical and biotechnological industries. Its direct participation in custom synthesis, pharmaceutical compound development, bioprocessing, and analytical research underscores its industrial value. The following sections detail verified downstream applications, reflecting current sector standards and industrial practices. 1. Peptide Synthesis for Pharmaceutical IntermediatesMajor pharmaceutical producers use L-Glutamine Methyl Ester Hydrochloride as a protected glutamine derivative in solid-phase and solution-phase peptide synthesis. Its methyl ester group protects the alpha-carboxyl site, permitting specific coupling reactions necessary in the stepwise assembly of therapeutic oligopeptides. This approach lowers racemization risk and increases yield when constructing sequences for peptide-based APIs, vaccines, and advanced intermediates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Cell Culture Media Additive in BioprocessingContract manufacturing organizations and bio-based production sites utilize this compound as a transient L-glutamine source in mammalian and microbial cell culture media. The methyl ester form offers increased stability during media preparation and storage, then gradually hydrolyzes to release free glutamine under physiological conditions, reducing ammonia buildup and supporting consistent protein expression in fed-batch processes. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Chemical Synthesis: Building Block for Pyroglutamate DerivativesManufacturers in fine chemical sectors leverage the methyl ester form of glutamine as a precursor in synthesizing custom N- and O-protected pyroglutamate derivatives. Its functional group reactivity supports cyclization and derivatization reactions required for pyrrolidone-based additives used in chemical auxiliaries, food modifiers, and certain crop protection agents. Reaction parameters are defined according to process safety, target molecule properties, and end-use application. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Analytical Reagent Formulation in Chromatography and ProteomicsProducers of chromatography solvents and proteomics kits blend the hydrochloride salt as a calibration standard and reagent for amino acid modification and quantification protocols. The material’s chemical stability and solubility promote accurate peptide mapping, mass spectrometry calibration, and labeling experiments. Batch consistency and documented traceability are priorities for laboratories and kit producers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Biomedical Research Compound LibrariesResearch institutions and custom synthesis firms include this compound in small-molecule libraries used for target validation, structure-activity relationship studies, and advanced screening projects. The methyl ester functionalization enables rapid modification via amidation or cross-coupling for lead compound optimization. Full analytical documentation and customizable packaging are required for research use under international quality standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive L-Glutamine Methyl Ester Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every year demands for specialized amino acid derivatives rise. Few stand out in performance and reliability like L-Glutamine Methyl Ester Hydrochloride (L-GME HCl). Over decades, hands in our industry have introduced essential chemical intermediates to both academia and application-driven fields. L-GME HCl carries a niche reputation because of its unique balance of reactivity and solubility—qualities rooted in its chemical structure, not marketing slogans.
L-Glutamine itself plays a fundamental role in biochemistry. Add a methyl ester and combine it with hydrochloride, and users gain a highly soluble, more stable form fit for demanding synthesis work. Chemists frequently encounter challenges with standard L-Glutamine: low stability, easy decomposition, and stubborn insolubility slow down research and downstream applications. Early R&D at our sites targeted each of these sticking points. We found that the methyl ester modification, coupled with hydrochloride counter-ion, preserves both the activity and easy handling properties needed for reliable results in both bench-scale and industrial synthesis.
L-GME HCl in our portfolio is produced in crystalline powder form, white to off-white in color, with controlled particle size for even dispersion. Quality hinges on controlling residual water content, achieving consistent particle texture, and nailing the purity that downstream conversions demand. We certify purity exceeding 99% on a dry basis and monitor both optical rotation and melting point to guarantee lot-to-lot reproducibility. Many researchers, especially in peptide research, depend on this consistency: batch variation can introduce error into custom synthesis or scale-up projects.
Down-to-earth, what does this mean for your team? The powder dissolves quickly in common solvents, both aqueous and selected organics. Stability at room temperature extends shelf life versus regular L-Glutamine, which tends to clump and degrade. Every jar sealed here reflects strict controls on inorganic chloride, heavy metals, and potential byproducts—removal verified by chromatography and spectroscopic checks before leaving our plant. In our experience, small oversights during production drive up purification steps for users. Getting it right at our end saves time at yours.
In synthetic chemistry, clients regularly ask where this methyl ester variant shines compared to other glutamine derivatives. Esterification transforms the amide group, enabling clean transformations under mild conditions for peptide coupling, methylation reactions, and protection-deprotection steps. It unlocks smooth pathways for N-methylation and esterifications that plain L-Glutamine or cheaper hydrochloride salts struggle to deliver.
Peptide chemists cite one main headache with unmodified L-Glutamine: glutamine’s side chain breaks down during coupling, forming unwanted pyroglutamyl artifacts. Over several years, we've fielded batch data and troubleshooting requests from academic and pharma laboratories. Time after time, L-GME HCl gave better recovery and fewer side reactions—especially during solid-phase synthesis. Smoother fissure between steps means less resin fouling and cleaner peptides, reducing post-synthesis purification.
We’ve also seen uptake in specialty fields such as biomedical imaging and development of protected amino acid libraries. Modest tweaks in methyl ester moieties helped advance probes and tracers—where purity, clarity, and chemical fidelity can’t be compromised. Analytical work from customer feedback routinely highlights that L-GME HCl’s enhanced solubility trims down the need for harsh dissolution aids or advanced equipment. Even newcomers to the field have relayed smoother work-ups and higher overall yields because the ester modification lowers the energy needed for key reactions.
Some might ask why not use the cheaper L-Glutamine hydrochloride, or the free base variant seen on the bulk market. Standard L-Glutamine lacks the methyl ester protection, which makes it prone to hydrolysis and cyclization—creating byproducts that confound synthesis and downstream isolation. Free base is even worse; moisture absorption and decomposition climb rapidly in humid labs. You get more waste than product, leading to higher costs and repeated runs. In contrast, L-GME HCl in crystalline powder shrugs off ambient humidity, with less than 0.5% water content in each lot.
Another difference is process control, not just chemistry. As manufacturers, we manage the esterification and acidification in a closed system, rigorously checked by in-process HPLC and NMR. From early scale-up work, we learned the perils of under-acidified or over-esterified intermediates: inconsistent product, ghost peaks, and even regulatory headaches for contract projects. Over time, we fine-tuned batch volumes and temperature schedules so every lot meets the same repeatable specs—for both GMP users and R&D explorers.
In peptide coupling and asymmetric syntheses—where every contaminant matters—L-GME HCl stands out for its high optical purity. Side-reactions and racemization haunt those relying on poorer base quality. We guarantee less than 0.1% D-isomer content. That isn’t a trivia stat; for those producing enantiomerically pure fine chemicals, even small deviations spoil entire syntheses downstream.
Producing L-GME HCl isn’t a simple one-pot, one-step affair. Over years of operation, our team optimized conditions to limit racemization and minimize batch-to-batch drifts. Operators watch moisture at every stage, stopping reactions both by titration and by real-time IR. Many forget that simple over-drying will cause decomposition and browning. Our in-plant experience taught us to control both oven humidity and transit time. This isn't just academics; real losses build up from tiny missteps.
Purification uses multi-stage crystallization, holding temperatures low to discourage inadvertent hydrolysis. Solvents are recycled and checked for cross-contamination, especially important for production lines that alternate with protected amino acid runs. We have stopped entire campaigns due to an unexpected impurity at the 20 ppm level, rather than risk downstream headaches for end users. Analytical backup comes by checking both the active content and trace iron, copper, and lead—industries from Europe to Japan typically enforce acute limits well below those in local regulations, so we calibrate to the strictest standard.
After final drying and sieving, every batch goes through both micron and endotoxin checks. Synthetic biologists working with next-generation protein building often combine L-GME HCl with automated assembly systems, so we maintain stringent microbial limits. This forward view has reduced client complaints and avoided disruption in sensitive applications like diagnostics and custom enzyme synthesis.
L-GME HCl draws direct interest for solution-phase and solid-phase peptide synthesis. The methyl ester group shields the sensitive side chain during harsh coupling conditions. Peptide specialists in both research and production have handled side-reactions tied to unmodified L-Glutamine, including chain truncations and pyroglutamate contamination. Clients working with oncology peptides and diagnostic reagents send positive notes—the methyl ester protection reduces the need for excess coupling agents and keeps solution clarity high, from small batches up to kilogram runs.
Vaccine companies and custom oligo shops have spoken about consistent uptake and improved batch stability using our grade. They pointed to improved solubility and fast dissolution. Scaling is smoother for pilot and commercial reactors, as the compound dissolves without the aggressive agitation or prolonged heating that other amino acid esters sometimes demand. One process chemist shared how L-GME HCl sped up a protected peptide scale by two hours per cycle, over several campaigns, which shaved off weeks in total project time.
Pharma partners also usher these benefits into other synthesis spaces, such as asymmetric intermediates and chiral auxiliaries. Speed matters, but so does reducing operator fatigue—a staff member once described it as “less wrestling with sticky, slow-dissolving powders.” Less time fighting with reagents means more time focusing on optimizing structures and increasing throughput.
Most user inquiries circle around handling and storage. Unlike free base glutamine, L-GME HCl copes with short exposures to ambient air, nearly always recovering to original dryness upon light resealing. Long-term, it stows safely in HDPE or glass, away from extreme heat. Key is dry, sealed environments—though user reports suggest less sensitivity than traditional amino esters. Our own internal stability studies back this up, with minimal drop-off after six months’ shelf exposure at laboratory room temperatures.
Chemists often ask about byproduct profiles and whether upgrades could improve even further on current grades. We track customer returns by batch, noting the rare instance of post-synthesis byproducts. The combination of improved purification protocols and better esterification helped slash rework rates by over 30% since 2018. Most feedback suggests purity and handling have reached a practical plateau; further gains come from tighter drying and improved particle sizing for automation platforms.
Less often, procurement teams ask whether switching to bulk forms (25 kg drums, larger) impacts quality. Our answer rests on batch track records: upscaling, if executed under tight controls, brings no observable drift in quality. Regular upsize trials, monitored at every production stage, gave us confidence for both small lab packs and commercial orders. Any size delivered, every batch walks through the full validation routine—purity, CLP compliance, absence of heavy metals, and microbial tests—and we keep real-time logs available for partner audits.
Regulatory landscapes shift yearly, with new standards for purity, traceability, and impurity limits. From our earliest days manufacturing L-GME HCl, we leaned toward exceeding regional benchmarks rather than aiming for the bare minimum. GLP and GMP users drive this: for applications near or touching the clinic, trace contaminants below parts-per-million spell the difference between market approval or costly rework. Collaborating with partners, we introduced dual analytical streams—both in-house and third-party—to spot-check these critical control points.
Best practices gained from experience teach that safe handling is not just a regulatory checkbox, but a matter of bottom-line protection. We ship L-GME HCl under sealed inert atmosphere when sending to tropical or highly humid regions, and investments in newer barrier packaging slashed oxygen ingress rates below detectable levels. Notices about safe handling and PPE requirements always accompany bulk shipments—not because of regulatory red tape, but because avoiding even one lost-time incident protects productivity and builds trust.
Every year, incremental changes in process control and packaging design surface from conversations with users. Our technical support often fields suggestions for lower-dust formulations and easier pourability—concerns that seem trivial until spilled powder or airborne fines cause losses during weigh-out. Feedback from peptide chemists, for example, steered us toward finer sieving and anti-static coatings on inner bags, which resulted in cleaner operation even at high-volume pilot plants.
Another concrete change emerged after listens to client feedback about dispensing accuracy. We now include tight-seal scoopers in larger packs by default, shaving off time-consuming weigh-out and reducing contamination risk at both ends of the workflow. Direct advice from users not only shapes process control and packaging, but seeps into our quality assessment regime. Test runs with external partners—under blinded conditions—prove the tough standards these projects demand.
Our QC team dedicates part of its workflow to tracking the minor deviations reported by users. Rather than chasing only product failures, regular communication about near-misses leads to proactive tweaks. In one memorable instance, a customer flagged a barely visible pale tint in a shipment. Though it fell within acceptance range, root-cause tracing teased out a batch of filter paper with an anomalous fiber blend. Fine-tuning both our investigation method and purchasing controls solved it and informed long-term procurement protocols.
Many buyers enter the market seeking amino acid derivatives by price or convenience. Long-term repeat customers learn that cutting a corner upstream—accepting a slightly lower purity, tolerating a higher moisture content, or accepting trace contaminants—carries hidden costs. Experience from the production floor shows that reliable purity, consistent powder flow, and repeatable reaction behavior flow more from process discipline than any clever sales line.
By investing steadily in both batch and process analytics, we shield our users—academic, industrial, or regulatory-facing—from the quiet pitfalls of inconsistent product. For L-GME HCl, regular equipment upgrades, validation studies, and recall drills shaped both our production mindset and our business interactions. We accept that inevitable small hiccups occur: it’s the speed and transparency of the response that counts most for users who rely on steady supply for complex, time-sensitive work.
The uses for L-Glutamine Methyl Ester Hydrochloride continue to evolve. Pharma, biotech, diagnostics, and specialty chemicals are testing new boundaries where enhanced solubility and protection against breakdown matter more every year. We’re constantly reviewing feedback not just for incremental improvements in current production, but for future upgrades that will support novel synthesis needs. Skipping speculation, every new adaptation returns to tough standards of purity, stability, and traceability learned from decades on the shop floor.
Lab staff, process engineers, and analytical chemists continue to shape the trajectory of this product as application areas expand—especially for challenging environments with sensitive reagents. As the conversation continues, user insight, process control, and up-to-the-minute regulatory awareness will guide the next refinements. Direct lines between production, technical support, and end-user feedback ensure that L-GME HCl stays not just a specialized chemical, but a reliable partner in tomorrow’s synthesis challenges.